Transpore Eye Tape for Eyelid Redness

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Eyelid RednessTranspore Eye Tape - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the rate of erythema, or redness, on the eyelids after anesthesia when a TegadermTM patch is used compared to a Transpore® patch. The hypothesis is that there will be no difference in the rate of erythema between the two groups.

Eligible Conditions
  • Eyelid Redness

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Immediately after tape removal

Immediately after tape removal
Edema
Epidermal Change
The proportion of eyelids with erythema at the end of surgery after removal of Tegaderm vs. Transpore

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

2 Treatment Groups

Transpore Right
1 of 2
Tegaderm Left
1 of 2

Experimental Treatment

165 Total Participants · 2 Treatment Groups

Primary Treatment: Transpore Eye Tape · No Placebo Group · Phase 4

Transpore Right
Device
Experimental Group · 1 Intervention: Transpore Eye Tape · Intervention Types: Device
Tegaderm Left
Device
Experimental Group · 1 Intervention: Tegaderm Eye Tape · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: immediately after tape removal

Who is running the clinical trial?

Tufts Medical CenterLead Sponsor
238 Previous Clinical Trials
244,818 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: